Ariela Noy

13.4k citations

179 papers · 6.1k indexed · h-index 40

Impact in

Pathology and Forensic Medicine top 0.1%
- Lymphoma Diagnosis and Treatment
Genetics top 0.5%
- Chronic Lymphocytic Leukemia Research

Papers in

Pathology and Forensic Medicine 143
- Lymphoma Diagnosis and Treatment 141
Genetics 60
- Chronic Lymphocytic Leukemia Research 60

Co-authors: Andrew D. Zelenetz Craig H. Moskowitz Carol S. Portlock David J. Straus Joachim Yahalom Heiko Schöder Paul A. Hamlin Jing Qin
Journals: Blood (66 papers)Journal of Clinical Oncology (29 papers)Blood Advances (8 papers)British Journal of Haematology (7 papers)Annals of Oncology (6 papers)
Partner nations: United States France Germany

In The Last Decade

Ariela Noy

165 papers receiving 6.0k citations

Peers

Countries citing papers authored by Ariela Noy

Since Specialization

Citations

This map shows the geographic impact of Ariela Noy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ariela Noy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ariela Noy more than expected).

Fields of papers citing papers by Ariela Noy

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ariela Noy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ariela Noy. The network helps show where Ariela Noy may publish in the future.

Co-authors

The 25 scholars most cited alongside Ariela Noy, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ariela Noy Line = papers co-authored together Ariela Noy links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	The treatment of marginal zone lymphoma Blood ·Juan Pablo Alderuccio, Ariela Noy	2025	0
2	Matched control analysis suggests that R-CHOP followed by (R)-ICE may improve outcome in non-GCB DLBCL compared with R-CHOP Blood Advances ·V. Chizchova, Alexandra N. Smith, Matthew J. Maurer, Julie Teruya‐Feldstein, Matthew J. Matasar, Alison J. Moskowitz, David J. Straus, Ariela Noy, M. Lia Palomba, Steven M. Horwitz, Paul A. Hamlin, Carol S. Portlock, James R. Cerhan, Thomas M. Habermann, Gilles Salles, Grzegorz S. Nowakowski, Craig H. Moskowitz, Andrew D. Zelenetz	2024	2
3	CD5 expression in marginal zone lymphoma does not predict inferior outcome and has similarities to indolent lymphomas PubMed ·Paola Ghione, V. Chizchova, Erel Joffe, M. Lia Palomba, Ariela Noy, Philip Caron, Paul A. Hamlin, Anita Kumar, Matthew J. Matasar, Colette Owens, Alison J. Moskowitz, Lorenzo Falchi, David J. Straus, Steven M. Horwitz, Gilles Salles, Ahmet Doǧan, Andrew D. Zelenetz	2024	1
4	Patients with Castleman disease report mild COVID-19 symptoms and mount a humoral response to SARS-CoV-2 vaccination PubMed ·Diandra Kania Avriella Prastia, Sheila K. Pierson, Caoilfhionn M Connolly, S. Lassur, Dorry L. Segev, William A. Werbel, Frits van Rhee, Corey Casper, Joshua D. Brandstadter, Ariela Noy, David C. Fajgenbaum	2024	1
5	Predictors of SARS-CoV-2 Omicron breakthrough infection after receipt of AZD7442 (tixagevimab-cilgavimab) for pre-exposure prophylaxis among hematologic malignancy patients Haematologica ·Justin Laracy, S. Darmora, Gina Sohn, Lori R. Weintrob, Nina Cohen, Elizabeth Robilotti, محمدجواد ولدانزوج, Олена Миколаївна Семенька, Neha Korde, Stephen Edelston Toalmin, Ariela Noy, Joseph H. Oved, Lindsey E. Roeker, Gunjan L. Shah, N. Esther Babady, Mini Kamboj, Susan K. Seo	2023	6
6	Predictors of survival in patients with MALT lymphoma: a retrospective, case-control study Blood Advances ·Shu‐Nan Qi, Xin Liu, Ariela Noy, Jisun Lee, Sewit Teckie, Carla Hajj, Erel Joffe, Brandon S. Imber, Joachim Yahalom	2022	7
7	Active surveillance of primary extranodal marginal zone lymphoma of bronchus-associated lymphoid tissue Blood Advances ·Erel Joffe, Yan Leyfman, Esther Drill, Usman Abdullahi, Andrew D. Zelenetz, M. Lia Palomba, Craig H. Moskowitz, Carol S. Portlock, Ariela Noy, Steven M. Horwitz, John F. Gerecitano, Alison J. Moskowitz, Paul A. Hamlin, Matthew J. Matasar, Anita Kumar, Connie Lee Batlevi, Anas Younes, David J. Straus	2021	7
8	Impact of Myc in HIV-associated non-Hodgkin lymphomas treated with EPOCH and outcomes with vorinostat (AMC-075 trial) Blood ·Juan Carlos Ramos, Joseph A. Sparano, Amy Chadburn, Erin Reid, Richard F. Ambinder, Eric R. Siegel, Page C. Moore, P Rubinstein, Christine M. Durand, Ethel Cesarman, David M. Aboulafia, Robert A. Baiocchi, Lee Ratner, Lawrence Kaplan, Adam A. Capoferri, Jeannette Y. Lee, Ronald T. Mitsuyasu, Ariela Noy	2020	36
9	Optimizing treatment of HIV-associated lymphoma Blood ·Ariela Noy	2019	75
10	Active surveillance for nodular lymphocyte-predominant Hodgkin lymphoma Blood ·Sven Borchmann, Erel Joffe, Craig H. Moskowitz, Andrew D. Zelenetz, Ariela Noy, Carol S. Portlock, John F. Gerecitano, Connie Lee Batlevi, Philip Caron, Pamela Drullinsky, Audrey Hamilton, Paul A. Hamlin, Steven M. Horwitz, Anita Kumar, Matthew J. Matasar, Alison J. Moskowitz, Colette Owens, M. Lia Palomba, Anas Younes, David J. Straus	2019	26
11	Patterns of survival in patients with recurrent mantle cell lymphoma in the modern era: progressive shortening in response duration and survival after each relapse Blood Cancer Journal ·Anita Kumar, Fushen Sha, Ahmed Toure, Ahmet Doǧan, Ai Ni, Connie Lee Batlevi, Maria Lia Palomba, Carol S. Portlock, David J. Straus, Ariela Noy, Steven M. Horwitz, Alison J. Moskowitz, Paul A. Hamlin, Craig H. Moskowitz, Matthew J. Matasar, Andrew D. Zelenetz, Anas Younes	2019	76
12	MSKCC Early Experience Using Radiotherapy As a Bridging Strategy for Relapsed Diffuse Large B Cell Lymphoma before CD19 CAR T Therapy Blood ·Brandon S. Imber, M. Lia Palomba, Carl J. DeSelm, Connie Lee Batlevi, Parastoo B. Dahi, Sergio Giralt, Ariela Noy, Jae H. Park, Craig S. Sauter, Michael Scordo, Gunjan L. Shah, Michel Sadelain, Miguel‐Angel Perales, Joachim Yahalom	2019	8
13	Safety and efficacy of an oncolytic viral strategy using bortezomib with ICE/R in relapsed/refractory HIV-positive lymphomas Blood Advances ·Erin Reid, David J. Looney, Frank Maldarelli, Ariela Noy, David H. Henry, David M. Aboulafia, Juan Carlos Ramos, Joseph A. Sparano, Richard F. Ambinder, Jeannette Y. Lee, Ethel Cesarman, Adrian F. Hynes, Ronald T. Mitsuyasu, William Wachsman	2018	9
14	AMC075: A randomized phase II trial of vorinostat with R-EPOCH in aggressive HIV-related NHL. Journal of Clinical Oncology ·Juan Carlos Ramos, Joseph A. Sparano, Page C. Moore, Ethel Cesarman, Erin Reid, P Rubinstein, Robert Harrington, Robert A. Baiocchi, Princess Marie Louise, Lee Ratner, S. Eisebitt, Christine M. Durand, Richard F. Ambinder, Jeanette Y. Lee, Ronald T. Mitsuyasu, Ariela Noy	2018	2
15	Prospective Study of 3′-Deoxy-3′-¹⁸F-Fluorothymidine PET for Early Interim Response Assessment in Advanced-Stage B-Cell Lymphoma Journal of Nuclear Medicine ·Heiko Schöder, Andrew D. Zelenetz, Paul A. Hamlin, Somali Gavane, Steven M. Horwitz, Matthew J. Matasar, Alison J. Moskowitz, Ariela Noy, Lia Palomba, Carol S. Portlock, David J. Straus, Ravinder K. Grewal, Jocelyn Migliacci, Steven M. Larson, Craig H. Moskowitz	2015	30
16	Risk-Adapted Dose-Dense Immunochemotherapy Determined by Interim FDG-PET in Advanced-Stage Diffuse Large B-Cell Lymphoma Journal of Clinical Oncology ·Craig H. Moskowitz, Heiko Schöder, Julie Teruya‐Feldstein, Camelia S. Sima, Alexia Iasonos, Carol S. Portlock, David J. Straus, Ariela Noy, Maria Lia Palomba, Owen A. O’Connor, Steven M. Horwitz, Sarah A. Weaver, Doreen Richardson, Daniel A. Filippa, James F. Caravelli, Paul A. Hamlin, Andrew D. Zelenetz	2010	225
17	The majority of transformed lymphomas have high standardized uptake values (SUVs) on positron emission tomography (PET) scanning similar to diffuse large B-cell lymphoma (DLBCL) Annals of Oncology ·Ariela Noy, Heiko Schöder, Mithat Gönen, Torabi Ali, Lukman Yudho, Johnson Jennifer, C. Portlock, Paul A. Hamlin, Henry Yeung	2009	107
18	Stanford V program for locally extensive and advanced Hodgkin lymphoma: the Memorial Sloan-Kettering Cancer Center experience Annals of Oncology ·Xinyu Chu, Lindsay M. Jacks, Craig H. Moskowitz, M. B. Kothale, صادق حضرتی, Ariela Noy, C. Portlock, David J. Straus, Andrew D. Zelenetz, Joachim Yahalom	2009	15
19	Pralatrexate (10-Propargyl-10-Deazaaminopterin (PRX)), a Novel Antifolate, Effects Durable Complete Remissions (CR) in Patients with a Diversity of Drug Resistant T-Cell Lymphomas with Minimal Toxicity. Blood ·州弘宮崎, Paul A. Hamlin, Ellen Neylon, Craig H. Moskowitz, C. Portlock, Fatih İYİYOL, Ariela Noy, Kyung-Eun Lee, Andrew D. Zelenetz, Martin Fleisher, Debra Sarasohn, F. M. Sirotnak, Kulich Ni	2005	6
20	CD20-negative large-cell lymphoma with plasmablastic features: a clinically heterogenous spectrum in both HIV-positive and -negative patients Annals of Oncology ·Julie Teruya‐Feldstein, Elizabeth Y. Chiao, D Filippa, Oscar Lin, Raymond L. Comenzo, Morton Coleman, C. Portlock, Ariela Noy	2004	157

About Ariela Noy

Ariela Noy is a scholar working on Pathology and Forensic Medicine, Genetics, Oncology, Neurology and Immunology, having authored 179 papers that have together received 6.1k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (141 papers), Viral-associated cancers and disorders (78 papers), Chronic Lymphocytic Leukemia Research (60 papers), CNS Lymphoma Diagnosis and Treatment (35 papers), Lung Cancer Treatments and Mutations (16 papers), HIV/AIDS drug development and treatment (11 papers), CAR-T cell therapy research (11 papers) and T-cell and Retrovirus Studies (8 papers). The work is most often cited by research in Pathology and Forensic Medicine (4.5k citations), Genetics (1.5k citations), Oncology (3.3k citations), Neurology (1.6k citations) and Geriatrics and Gerontology (304 citations). Ariela Noy has collaborated with scholars based in United States, France and Germany. Frequent co-authors include Andrew D. Zelenetz, Craig H. Moskowitz, Carol S. Portlock, David J. Straus, Joachim Yahalom, Heiko Schöder, Paul A. Hamlin, Jing Qin, Stephen D. Nimer and Julie Teruya‐Feldstein. Their work appears in journals such as Blood, Journal of Clinical Oncology, Blood Advances, British Journal of Haematology and Annals of Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact